Low-molecular-weight or Unfractionated Heparin in Venous Thromboembolism: The Influence of Renal Function

Abstract Background In patients with acute venous thromboembolism and renal insufficiency, initial therapy with unfractionated heparin may have some advantages over low-molecular-weight heparin. Methods We used the Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Registry data to evaluate the 15-day outcome in 38,531 recruited patients. We used propensity score matching to compare patients treated with unfractionated heparin with those treated with low-molecular-weight heparin in 3 groups stratified by creatinine clearance levels at baseline: >60 mL/min, 30 to 60 mL/min, or 60 mL/min (n = 1598 matched pairs), 30 to 60 mL/min (n = 277 matched pairs), and 60 mL/min or